Anwar, N., Badar, F., Yusuf, M.A., 2008. Profile of patients with colorectal cancer at a tertiary care cancer hospital in Pakistan. Ann. N. Y. Acad. Sci. 1138, 199–203.
Bhurgri, Y., Khan, T., Kayani, N., Ahmad, R., Usman, A., Bhurgri, A., Bashir, I., Hasan, S., Zaidi, S.M.H., 2011. Incidence and current trends of colorectal malignancies in an unscreened, low risk population. Asian Pacific J. Cancer Prev. 12, 703–708.
Brigger, I., Dubernet, C., Couvreur, P., 2012. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 64, 24–36.
Frebourg, T., Friend, S.H., 1992. Cancer risks from germline p53 mutations. J. Clin. Invest. 90, 1637–1641.
Gao, Z.-G., Yang, Y., Han, X.-F., Wang, Y.-L., Wang, Z.-J., 2020. ALDH3B2 Polymorphism Is Associated with Colorectal Cancer Susceptibility. J. Oncol. 2020, 5179635. https://doi.org/10.1155/2020/5179635
George, B., Datar, R.H., Wu, L., Cai, J., Patten, N., Beil, S.J., Groshen, S., Stein, J., Skinner, D., Jones, P.A., 2007. p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer. J. Clin. Oncol. 25, 5352–5358.
Ghorbani, F., Kokhaei, P., Ghorbani, M., Eslami, M., 2020. Application of different nanoparticles in the diagnosis of colorectal cancer. Gene Reports 21, 100896. https://doi.org/https://doi.org/10.1016/j.genrep.2020.100896
Haggar, F.A., Boushey, R.P., 2009. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin. Colon Rectal Surg. 22, 191.
Hasan, F., Shah, S.M.M., Munaf, M., Khan, M.R., Marsia, S., Haaris, S.M., Shaikh, M.H., Rahim, I.A., Anwar, M.S., Qureshi, K.S., 2017. Barriers to colorectal cancer screening in Pakistan. Cureus 9.
Iacopetta, B., Russo, A., Bazan, V., Dardanoni, G., Gebbia, N., Soussi, T., Kerr, D., Elsaleh, H., Soong, R., Kandioler, D., 2006. Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann. Oncol. 17, 842–847.
Kakakhel, M.A., Wu, F., Gu, J.-D., Feng, H., Shah, K., Wang, W., 2019. Controlling biodeterioration of cultural heritage objects with biocides: A review. Int. Biodeterior. Biodegradation 143, 104721. https://doi.org/10.1016/j.ibiod.2019.104721
Moghimi-Dehkordi, B., Safaee, A., 2012. An overview of colorectal cancer survival rates and prognosis in Asia. World J. Gastrointest. Oncol. 4, 71.
Naccarati, A., Polakova, V., Pardini, B., Vodickova, L., Hemminki, K., Kumar, R., Vodicka, P., 2012. Mutations and polymorphisms in TP53 gene—an overview on the role in colorectal cancer. Mutagenesis 27, 211–218.
Nejad, A.L., Yaghoobi, M.M., 2012. Mutation analysis of TP53 tumor suppressor gene in colorectal cancer in patients from Iran (Kerman Province). Iran. J. Basic Med. Sci. 15, 683.
Olivier, M., Hollstein, M., Hainaut, P., 2010. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb. Perspect. Biol. 2, a001008.
Osumi, H., Shinozaki, E., Yamaguchi, K., Zembutsu, H., 2019. Early change in circulating tumor DNA as a potential predictor of response to chemotherapy in patients with metastatic colorectal cancer. Sci. Rep. 9, 1–9.
Qadir, M., Ghalia, B.A., 2018. Awareness survey about colorectal cancer in students of M. Phil Biotechnology at Bahauddin Zakariya University, Multan, Pakistan. Nov Appro Can Study 1.
Rehman, G., Gul, N., Khan, G.N., Zaman, K., Anwar, Z., Kakakhel, M.A., 2020. Ethanolic extract of Allacanthos crab inhibits cancer cell proliferation, posses anti-inflammatory and antioxidant potentials. Gene Reports 21. https://doi.org/10.1016/j.genrep.2020.100907
Roth, J.A., 1999. p53 prognostication: Paradigm or paradox? Clin. Cancer Res. 5, 3345.
Sharma, A., Alatise, O.I., Adisa, A.O., Arowolo, O.A., Olasehinde, O., Famurewa, O.C., Omisore, A.D., Komolafe, A.O., Olaofe, O., Katung, A.I., 2020. Treatment of colorectal cancer in Sub‐Saharan Africa: Results from a prospective Nigerian hospital registry. J. Surg. Oncol. 121, 342–349.
Siegel, R.L., Miller, K.D., 2015. jemal A: Cancer statistics, 2015. CA Cancer j Clin 65, 5–29.
Tominaga, T., Iwahashi, M., Takifuji, K., Hotta, T., Yokoyama, S., Matsuda, K., Higashiguchi, T., Oku, Y., Nasu, T., Yamaue, H., 2010. Combination of p53 codon 72 polymorphism and inactive p53 mutation predicts chemosensitivity to 5‐fluorouracil in colorectal cancer. Int. J. cancer 126, 1691–1701.
Warwick, P.D., 2007. Overview of the geography, geology and structure of the Potwar regional framework assessment project study area, north-ern Pakistan. Reg. Stud. Potwar Plateau Area, North. Pakistan. US Geol. Surv. Bull 2078.
Yu, J., Wu, W.K.K., Li, X., He, J., Li, X.-X., Ng, S.S.M., Yu, C., Gao, Z., Yang, J., Li, M., 2015. Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer. Gut 64, 636–645.
Zhang, X., Wang, W., Wang, Y., Jia, D., Zhu, L., 2018. Human papillomavirus infection and colorectal cancer in the Chinese population: a meta‐analysis. Color. Dis. 20, 961–969.